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More than 13 billion years ago, the universe emerged and
continued expending after the Big Bang. 4.6 billion Years
ago, our earth was formed in solar system with no oxygen
and no any signs of life. 3.8 billion years ago, primitive ele-
ments of life of RNA and DNA were accidently formed
within rocky vent in deep water of Atlantic Ocean. From
single cell to multiple cell life, and to multi-organ species,
it took billions years. The ocean turned blue, the land got
green and oxygen fills our air. The life started move on to
the land. The lives were evolving for adapting with the
surrounding environment and the forms of life were
diversified.
However, inside each basic block of life, the cell, our
common ancestor inscribed the deep common marks.
From genome to protein, to signal transduction, to orga-
nelles, to cell membrane, we all life on earth are in a big
family. This is the basis for our human who benefit from
using our sister species to do medical experiments.
The fates of life are also in common. Through the jour-
ney of birth, growth, aging and death, we all reach the
same destiny. Cells are subject to the fates of senescence,
mutation, apoptosis, and necrosis. The clock of life is tick-
ling down in according with the shortening of telomeres.
Once our tissue is injured, regardless of either from
inside of autoimmune response or metabolic disorder, or
from outside micro-organism invasion or traumatic
damage, our repairing potential is intrigued, which induces
the common reactions include inflammatory cells infiltra-
tion, extracellualr matrix formation. Once the damage is
repaired, the inflammatory cells commit programed death,
the apoptosis, and healing is achieved. If the injure con-
tinues and inflammation persists, the fibrosis and scaring
process dominate, and then, the organ lost function and
slides to end stage.
Understanding the nature of common origin of life and
exploring common path of disease would help us to see a
big picture about life science, and lead to generate big
ideas to deal with disease. With integration of multi-
discipline collaborations, the common targets for treat-
ment of diseases are being identified and right strategies
can be developed. Efficiently developing new drugs and
wisely applying old ones, rationally combining biologic
with small molecule, focusing on both physical and men-
tal would speed successes in translation and achieve the
healthy lives in human being, and even dial the life clock
back.
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